A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

• Authors : Boulware, D. R.; Pullen, M. F.; Bangdiwala, A. S.

• Source: New England Journal of Medicine (N ENGL J MED), 8/6/2020; 383(6): 517-525. (9p)

Record details

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial

• Authors : Rhein, Joshua; Huppler Hullsiek, Kathy; Tugume, Lillian

• Source: In The Lancet Infectious Diseases August 2019 19(8):843-851

Record details

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

• Authors : Cresswell, Fiona V ^{a, c, d, *}; Tugume, Lillian ^c; Bahr, Nathan C ^e

• Source: In The Lancet Infectious Diseases March 2020 20(3):308-317

Record details

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.

• Authors : Skipper, Caleb P. (); Pastick, Katelyn A. (); Engen, Nicole W. ()

• Source: Annals of Internal Medicine. 10/20/2020, Vol. 173 Issue 8, p623-631. 9p. 2 Diagrams, 1 Chart, 3 Graphs.

• Abstract: Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in ...

Record details

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study

• Authors : Williams, Darlisha A; Taseera, Kabanda; Nyehangane, Dan

• Source: In The Lancet Infectious Diseases January 2018 18(1):68-75

Record details

Post-Transplant Malignancy after Pediatric Kidney Transplantation: Retrospective Analysis of Incidence and Risk Factors in 884 Patients Receiving Transplants Between 1963 and 2015 at the University of Minnesota

• Authors : Serrano, Oscar K. ^{a, ∗}; Bangdiwala, Ananta S. ^b; Vock, David M. ^c

• Source: In Journal of the American College of Surgeons August 2017 225(2):181-193

Record details

Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.

• Authors : Boulware, David R; Nalintya, Elizabeth; Rajasingham, Radha

• Source: Medical Mycology; Nov2020, Vol. 58 Issue 8, p1037-1043, 7p

• Abstract: Cryptococcal antigen (CrAg) screening in HIV-infected persons with CD4 Copyright of Medical Mycology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites ...

Record details

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.

• Authors : Lofgren, Sarah M; Nicol, Melanie R; Bangdiwala, Ananta S

Subjects: DRUG side effects; COVID-19; HYDROXYCHLOROQUINE

• Source: Open Forum Infectious Diseases; Nov2020, Vol. 7 Issue 11, p1-7, 7p

• Abstract: Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease 2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. Here, we report safety data ... Copyright of Open Forum Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to ...

Record details

Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.

• Authors : Pullen, Matthew F; Hullsiek, Katherine Huppler; Rhein, Joshua

Subjects: CEREBROSPINAL fluid examination; AMPHOTERICIN B; ANTIFUNGAL agents

• Source: Clinical Infectious Diseases; Oct2020, Vol. 71 Issue 7, pe45-e49, 5p

• Abstract: Background In cryptococcal meningitis phase 2 clinical trials, early fungicidal activity (EFA) of Cryptococcus clearance from cerebrospinal fluid (CSF) is used as a surrogate endpoint for ... Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple ...

Record details

Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.

• Authors : Lother, Sylvain A.; Abassi, Mahsa; Agostinis, Alyssa

• Source: Canadian Journal of Anaesthesia; Sep2020, Vol. 67 Issue 9, p1201-1211, 11p

• Abstract: Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there is a lack of evidence-based therapies ... Résumé: Contexte: Le syndrome respiratoire aigu sévère du coronavirus 2 (SARS-CoV-2) est apparu en décembre 2019, provoquant la pandémie de la COVID-19. À ... Copyright of Canadian Journal of Anaesthesia is the property of Springer Nature and its content may not be copied or emailed to multiple sites ...

Record details